메뉴 건너뛰기
International Journal of Palliative Nursing
Volumn 16, Issue 12, 2010, Pages 576-
The use of bevacizumab for the treatment of colorectal cancer
Author keywords

[No Author keywords available]
Indexed keywords

EID: 78650864452     PISSN: 13576321     EISSN: None     Source Type: Journal    
DOI: 10.12968/ijpn.2010.16.12.576     Document Type: Note
Times cited : (1)
References (3)
  • 1
    • 2542561964 scopus 로고    scopus 로고
    • Bevacizumab, plus irinotecan, fluorouracil (5-FU) and leucovorin for metastatic colorectal cancer
    • Hurwitz H, Fehrenbacher L, Novotny W, et al (2004) Bevacizumab, plus irinotecan, fluorouracil (5-FU) and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-42
    • (2004) N Engl J Med , vol.350 , pp. 2335-2342
    • Hurwitz, H.1    Fehrenbacher, L.2    Novotny, W.3
  • 2
    • 70349690209 scopus 로고    scopus 로고
    • Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial
    • Okines A, Puerto OD, Cunningham D, et al (2009) Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial. Br J Cancer 101(7): 1033-8
    • (2009) Br J Cancer , vol.101 , Issue.7 , pp. 1033-1038
    • Okines, A.1    Puerto, O.D.2    Cunningham, D.3
  • 3
    • 42949149159 scopus 로고    scopus 로고
    • Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized Phase III study
    • Saltz LB, Clarke S, Díaz-Rubio E, et al (2008) Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized Phase III study. J Clin Oncol 26(12): 2013-19
    • (2008) J Clin Oncol , vol.26 , Issue.12 , pp. 2013-2019
    • Saltz, L.B.1    Clarke, S.2    Díaz-Rubio, E.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.